CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Cerenome Launches CNSide® CSF Molecular Profile Tests

CNSide® CSF Molecular Profile TestsPositive
AI Analysis

Summary

Cerenome launched two CNSide CSF molecular profiling tests for CNS cancer detection, expanding its DNA and RNA testing capabilities. The tests are available as of October 12, 2026.

Importance:3/10
Sentiment:
0.30
product launchmolecular testingCNS oncologyDNA/RNA testing
Related Companies

Read the original article

Published by GlobeNewswire Pharma on October 6, 2026 11:30 AM

Read Original